SMYD2 and pachyonychia congenita: The literature has not addressed the role of SMYD2 in PC, but the closely related SMYD family member SMYD3 proved a valid molecular target in PC since it modulates transcriptional and key signaling pathways and orchestrates multiple oncogenic inputs [22].